Molecular Determinants of Macrophage Polarization in Glioblastoma and Implications for Tumor Progression
Cells · 13.03.2026 · 15 (6) · 508
DOI: 10.3390/cells15060508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 13.03.2026. Verfasst von Xiao-Xiao Luo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Glioblastoma, Macrophages, Disease Progression, Brain Neoplasms. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Provincial Natural Science Foundation, National Natural Sciences Foundation of China, National Health Council Foundation of China.
Abstract (Originalsprache)
Glioblastoma (GBM) is a highly aggressive brain tumor with a complex tumor microenvironment (TME) that includes immune cell infiltration, notably macrophages. The role of macrophages in GBM progression is influenced by their polarization state, which can be either pro-inflammatory (M1) or immunosuppressive (M2). This study investigates the macrophage polarization in GBM, identifying key macrophage-related genes and their impact on tumor progression. Analysis of TCGA-GBM data revealed that macrophage infiltration correlates with poor prognosis, with 41 risk-associated genes identified. DSP dataset analysis highlighted 378 differentially expressed genes between CD68+ macrophages and GFAP+ controls, including immune-related genes like SPP1, CD74, and C3. Cross-validation with single-cell RNA-seq confirmed the expression of 9 key genes, with 7 genes being macrophage-specific. In vitro experiments using conditioned media from GBM cell lines demonstrated that GBM cells promote macrophage polarization towards an M2-like phenotype. Overexpression of CD74, CLEC7A, and IFI30 in macrophages further enhanced M2 polarization, which was associated with increased tumor-promoting functions, including enhanced invasion and reduced apoptosis in GBM cells. Together, these findings highlight the role of M2 macrophage polarization in promoting GBM progression and suggest that targeting macrophage polarization pathways may offer therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
- Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
- Department of Public Health, School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.
- Department of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
ORCID-Profile: Min Fu, Shi-Yong Li, Ying-Jia Hu
Förderung
- Hubei Provincial Natural Science Foundation
- National Natural Sciences Foundation of China
- National Health Council Foundation of China
Zitieren
APA
Luo, X. X., Fu, M., Zhao, B., Yang, F., Liu, Y. Z., Peng, X. H., Li, S. Y., Zhan, G. F., Hu, Y. J., Hu, G. Y., Cheng, H. H., & Li, Q. X. (2026). Molecular Determinants of Macrophage Polarization in Glioblastoma and Implications for Tumor Progression. Cells, 15(6), 508. https://doi.org/10.3390/cells15060508
Vancouver
Luo XX, Fu M, Zhao B, Yang F, Liu YZ, Peng XH, et al. Molecular Determinants of Macrophage Polarization in Glioblastoma and Implications for Tumor Progression. Cells. 2026;15(6):508. doi:10.3390/cells15060508
BibTeX
@article{Luo2026,
author = {Luo, Xiao-Xiao and Fu, Min and Zhao, Ben and Yang, Feng and Liu, Yi-Zhou and Peng, Xiao-Hong and Li, Shi-Yong and Zhan, Gao-Feng and Hu, Ying-Jia and Hu, Guang-Yuan and Cheng, Heng-Hui and Li, Qian-Xia},
title = {Molecular Determinants of Macrophage Polarization in Glioblastoma and Implications for Tumor Progression},
journal = {Cells},
year = {2026},
volume = {15},
number = {6},
pages = {508},
doi = {10.3390/cells15060508}
}
EUVIMED